Search for grants with us!
Grants you might be eligible for
Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3 - Clinical Trial Optional)
PAR-25-170
Programme: NIH Grants
GRANT OVERVIEW
ELIGIBILITY CRITERIA
Funding
Up to None USD
Eligible Participants
Deadline
June 22, 2026, 9 p.m.
Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
PAR-25-040
Programme: Mental Health Research Grants
Up to 275000.00 USD
Sept. 7, 2026, 4 a.m.
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
PAR-25-297
Programme: National Institutes of Health (NIH)
Up to 1500000.00 USD
Nov. 5, 2027, 10 p.m.
Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)
PAR-25-211
Up to 350000.00 USD
June 2, 2027, 10 p.m.
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)
PAR-25-216
Programme: NIH Research Career Development
Nov. 12, 2027, 10 p.m.
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)
PAR-25-243
Jan. 7, 2028, 10 p.m.
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
PAR-25-026
Up to 1515000.00 USD
Jan. 7, 2027, 10 p.m.
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)
PAR-25-044
Up to 200000.00 USD
NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
PAR-25-188
Programme: NIDCR
Grant Overview
Eligibility Criteria
Up to 500000.00 USD
Jan. 6, 2028, 10 p.m.
Clinical and Translational Science Award (UM1 Clinical Trial Optional)
PAR-24-272
Programme: Clinical and Translational Science Award (CTSA)
Sept. 28, 2027, 9 p.m.
NIH HEAL Initiative PainCare Clinician Training Program (PCTP): Mentored Patient-Oriented Research Career Development award (K23 - Clinical Trial Required)
PAR-24-220
Programme: NIH HEAL Initiative
July 12, 2027, 9 p.m.
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
PAR-25-025
BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional)
RFA-MH-26-140
Programme: BRAIN Initiative
June 15, 2027, 9 p.m.
Microglial Pathophysiology in Comorbid Substance Use Disorder (SUD) and HIV (R61/R33 Clinical Trial Not Allowed)
RFA-DA-25-063
Aug. 14, 2025, 10 p.m.
Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)
PAR-25-179
Oct. 15, 2027, 10 p.m.
Pilot Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 Clinical Trial Required)
PAR-25-178
Up to 750000.00 USD
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional)
PA-25-294
Sept. 7, 2025, 9 p.m.
NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed)
PAR-24-321
Programme: NIH Research Career Development Program
Up to 150000.00 USD
BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)
RFA-NS-25-021
Sept. 28, 2026, 9 p.m.
Co-infection and Cancer (R01 Clinical Trial Not Allowed)
PAR-25-082
Programme: Cancer Cause and Prevention Research
Jan. 7, 2026, 10 p.m.
789 results. Page 6 of 40.